Detalhe da pesquisa
1.
Emerging Cellular Therapies for Cancer.
Annu Rev Immunol;
37: 145-171, 2019 04 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30526160
2.
Mitigation of chromosome loss in clinical CRISPR-Cas9-engineered T cells.
Cell;
186(21): 4567-4582.e20, 2023 10 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37794590
3.
CAR T therapy extends its reach to autoimmune diseases.
Cell;
185(24): 4471-4473, 2022 11 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36423579
4.
Adoptive immunotherapy for cancer or viruses.
Annu Rev Immunol;
32: 189-225, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24423116
5.
The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function.
Cell;
184(19): 4981-4995.e14, 2021 09 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34464586
6.
An NK-like CAR T cell transition in CAR T cell dysfunction.
Cell;
184(25): 6081-6100.e26, 2021 12 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34861191
7.
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies.
Cell;
183(1): 126-142.e17, 2020 10 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32961131
8.
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade.
Cell;
178(4): 933-948.e14, 2019 08 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31398344
9.
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.
Immunity;
56(10): 2388-2407.e9, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37776850
10.
The Principles of Engineering Immune Cells to Treat Cancer.
Cell;
168(4): 724-740, 2017 02 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28187291
11.
Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers.
Immunity;
55(3): 557-574.e7, 2022 03 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35263570
12.
CAR T therapy beyond cancer: the evolution of a living drug.
Nature;
619(7971): 707-715, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37495877
13.
Potentiating adoptive cell therapy using synthetic IL-9 receptors.
Nature;
607(7918): 360-365, 2022 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35676488
14.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature;
602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35110735
15.
Beyond youth: Understanding CAR T cell fitness in the context of immunological aging.
Semin Immunol;
70: 101840, 2023 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37729825
16.
IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation.
Proc Natl Acad Sci U S A;
121(13): e2319856121, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38513098
17.
Enhancing chimeric antigen receptor T cell therapy by modulating the p53 signaling network with Δ133p53α.
Proc Natl Acad Sci U S A;
121(10): e2317735121, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38408246
18.
Exploiting the CD200-CD200R immune checkpoint axis in multiple myeloma to enhance CAR T-cell therapy.
Blood;
143(2): 139-151, 2024 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37616575
19.
Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells.
Proc Natl Acad Sci U S A;
120(12): e2218632120, 2023 03 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36920923
20.
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood;
141(6): 609-619, 2023 02 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36351239